{"accession":"0001628280-26-050134","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-050134/OperatingIncomeLoss","change":-0.17495126705653022,"cik":1800,"company":"ABBOTT LABORATORIES","concept":{"label":"Operating income","label_en":"Operating income","label_ko":"\uc601\uc5c5\uc774\uc775","period_type":"duration","xbrl_tag":"OperatingIncomeLoss"},"filed_at":"2026-07-28","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/0001628280-26-050134-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-050134","form":"10-Q","id":"0001628280-26-050134/OperatingIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm#f-61","unit":"USD","value":1693000000.0,"xbrl_fact_id":"f-61"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm#f-62","unit":"USD","value":2052000000.0,"xbrl_fact_id":"f-62"}],"statement":"ABBOTT LABORATORIES (ABT) reported Operating income of USD 1,693,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0001628280-26-050134, filed 2026-07-28).","ticker":"ABT","url":"https://aiswingx.com/n/0001628280-26-050134/OperatingIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm#f-61"}